{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:20:30Z","timestamp":1790835630638,"version":"4.1.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25ck0106060h"],"award-info":[{"award-number":["25ck0106060h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project Mirai Cancer Research Grants"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are\n                    <jats:italic>bona fide<\/jats:italic>\n                    cystic precursor lesions to pancreatic ductal adenocarcinoma (PDAC), which is the cancer type with the most dismal prognosis. Since IPMNs are detectable by imaging, they offer a rare window of opportunity for early intervention for PDAC development. Despite their clinical visibility, the molecular pathogenesis of IPMNs remained incompletely understood, and no effective non-surgical therapeutic strategies have been established to date. In the past few decades, however, substantial progress has been made in elucidating their molecular pathology. Next-generation sequencing technologies demonstrated the comprehensive genetic mutation profile of IPMNs in the early 2010s. Elucidation of these mutation profiles enabled the establishment of genetically engineered mouse models, successfully recapitulating the natural development of human IPMNs and their progression to invasive cancer. Rapid evolution of \u201comics\u201d technologies in recent years has facilitated the application of mass spectrometry, single-cell sequencing and spatial transcriptomics to IPMNs, significantly advancing our understanding of their pathophysiology. These techniques elucidated the changes in transcriptome, proteome, metabolome, microbiome, and tumor microenvironment associated with IPMN development and progression. This review summarizes current insights into the molecular and cellular landscapes of IPMN tumorigenesis, with particular emphasis on the mechanisms driving malignant progression.\n                  <\/jats:p>","DOI":"10.1007\/s00535-025-02328-7","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:34:06Z","timestamp":1764138846000},"page":"909-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-4548","authenticated-orcid":false,"given":"Yuki","family":"Makino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohki","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik Ivar","family":"Thege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"8","key":"2328_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, di Pasca Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186(8):1729\u201354. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014.","journal-title":"Cell"},{"issue":"3","key":"2328_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s43018-022-00349-2","volume":"3","author":"AN Hosein","year":"2022","unstructured":"Hosein AN, Dougan SK, Aguirre AJ, Maitra A. Translational advances in pancreatic ductal adenocarcinoma therapy. Nat Cancer. 2022;3(3):272\u201386. https:\/\/doi.org\/10.1038\/s43018-022-00349-2.","journal-title":"Nat Cancer"},{"issue":"5","key":"2328_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3322\/caac.21626","volume":"70","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020;70(5):375\u2013403. https:\/\/doi.org\/10.3322\/caac.21626.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2328_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4(4):e214708. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4708.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2328_CR5","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, Koay EJ, Chari ST, Maitra A. Early Detection of Pancreatic Cancer: opportunities and challenges. Gastroenterology. 2019;156(7):2024\u201340. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.259.","journal-title":"Gastroenterology"},{"key":"2328_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41568-024-00744-0","volume":"24","author":"J Faupel-Badger","year":"2024","unstructured":"Faupel-Badger J, Kohaar I, Bahl M, et al. Defining precancer: a grand challenge for the cancer community. Nat Rev Cancer. 2024;24:792\u2013809. https:\/\/doi.org\/10.1038\/s41568-024-00744-0.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2328_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1158\/2159-8290.CD-23-1550","volume":"14","author":"MM Stangis","year":"2024","unstructured":"Stangis MM, Chen Z, Min J, Glass SE, Jackson JO, Radyk MD, et al. The hallmarks of precancer. Cancer Discov. 2024;14(4):683\u20139. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1550.","journal-title":"Cancer Discov"},{"key":"2328_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MPA.0000000000000999","volume":"47","author":"AL Fonseca","year":"2018","unstructured":"Fonseca AL, Kirkwood K, Kim MP, et al. Intraductal papillary mucinous neoplasms of the pancreas: current understanding and future directions for stratification of malignancy risk. Pancreas. 2018;47:272\u20139. https:\/\/doi.org\/10.1097\/MPA.0000000000000999.","journal-title":"Pancreas"},{"key":"2328_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223825","author":"D Moris","year":"2024","unstructured":"Moris D, Liapis I, Gupta P, et al. An overview for clinicians on intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16223825.","journal-title":"Cancers (Basel)"},{"key":"2328_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcancer.2024.12.005","volume":"109","author":"C Corradi","year":"2025","unstructured":"Corradi C, Gentiluomo M, Adsay V, Sainz J, Camisa PR, Wlodarczyk B, et al. Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. Semin Cancer Biol. 2025;109:25\u201343. https:\/\/doi.org\/10.1016\/j.semcancer.2024.12.005.","journal-title":"Semin Cancer Biol"},{"key":"2328_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1053\/j.gastro.2024.02.041","volume":"167","author":"TB Gardner","year":"2024","unstructured":"Gardner TB, Park WG, Allen PJ. Diagnosis and management of pancreatic cysts. Gastroenterology. 2024;167:454\u201368. https:\/\/doi.org\/10.1053\/j.gastro.2024.02.041.","journal-title":"Gastroenterology"},{"key":"2328_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","volume":"24","author":"T Ohtsuka","year":"2024","unstructured":"Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24:255\u201370. https:\/\/doi.org\/10.1016\/j.pan.2023.12.009.","journal-title":"Pancreatology"},{"issue":"7","key":"2328_CR13","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cgh.2008.04.022","volume":"6","author":"MD Bishop","year":"2008","unstructured":"Bishop MD, Wallace MB. Intraductal papillary mucinous neoplasms of the pancreas: should we side step the side branches? Clin Gastroenterol Hepatol. 2008;6(7):724\u20135. https:\/\/doi.org\/10.1016\/j.cgh.2008.04.022.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2328_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002543","volume":"3","author":"J Wu","year":"2011","unstructured":"Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:92ra66. https:\/\/doi.org\/10.1126\/scitranslmed.3002543.","journal-title":"Sci Transl Med"},{"key":"2328_CR15","doi-asserted-by":"publisher","first-page":"21188","DOI":"10.1073\/pnas.1118046108","volume":"108","author":"J Wu","year":"2011","unstructured":"Wu J, Jiao Y, Dal Molin M, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A. 2011;108:21188\u201393. https:\/\/doi.org\/10.1073\/pnas.1118046108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2328_CR16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.pan.2023.08.002","volume":"23","author":"LD Wood","year":"2023","unstructured":"Wood LD, Adsay NV, Basturk O, et al. Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms. Pancreatology. 2023;23:878\u201391. https:\/\/doi.org\/10.1016\/j.pan.2023.08.002.","journal-title":"Pancreatology"},{"issue":"11","key":"2328_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/pin.13272","volume":"72","author":"T Furukawa","year":"2022","unstructured":"Furukawa T. Mechanisms of development and progression of pancreatic neoplasms. Pathol Int. 2022;72(11):529\u201340. https:\/\/doi.org\/10.1111\/pin.13272.","journal-title":"Pathol Int"},{"key":"2328_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191937","author":"BA Pedro","year":"2025","unstructured":"Pedro BA, Wood LD. Early neoplastic lesions of the pancreas: initiation, progression, and opportunities for precancer interception. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI191937.","journal-title":"J Clin Invest"},{"issue":"12","key":"2328_CR19","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","volume":"39","author":"O Basturk","year":"2015","unstructured":"Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, et al. A revised classification system and recommendations from the Baltimore Consensus Meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol. 2015;39(12):1730\u201341. https:\/\/doi.org\/10.1097\/PAS.0000000000000533.","journal-title":"Am J Surg Pathol"},{"key":"2328_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215296","author":"J Li","year":"2021","unstructured":"Li J, Wei T, Zhang J, et al. Intraductal papillary mucinous neoplasms of the pancreas: a review of their genetic characteristics and mouse models. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13215296.","journal-title":"Cancers (Basel)"},{"key":"2328_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16061183","author":"Y Hu","year":"2024","unstructured":"Hu Y, Jones D, Esnakula AK, et al. Molecular pathology of pancreatic cystic lesions with a focus on malignant progression. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16061183.","journal-title":"Cancers (Basel)"},{"key":"2328_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00428-020-02806-8","volume":"477","author":"Y Omori","year":"2020","unstructured":"Omori Y, Ono Y, Kobayashi T, et al. How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression. Virchows Arch. 2020;477:21\u201331. https:\/\/doi.org\/10.1007\/s00428-020-02806-8.","journal-title":"Virchows Arch"},{"issue":"1","key":"2328_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/SLA.0b013e31828cd008","volume":"258","author":"N Ideno","year":"2013","unstructured":"Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, et al. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg. 2013;258(1):141\u201351. https:\/\/doi.org\/10.1097\/SLA.0b013e31828cd008.","journal-title":"Ann Surg"},{"issue":"2","key":"2328_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/SLA.0b013e318287ab73","volume":"258","author":"M Distler","year":"2013","unstructured":"Distler M, Kersting S, Niedergethmann M, Aust DE, Franz M, R\u00fcckert F, et al. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg. 2013;258(2):324\u201330. https:\/\/doi.org\/10.1097\/SLA.0b013e318287ab73.","journal-title":"Ann Surg"},{"key":"2328_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/cncr.10203","volume":"94","author":"NV Adsay","year":"2002","unstructured":"Adsay NV, Conlon KC, Zee SY, et al. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer. 2002;94:62\u201377. https:\/\/doi.org\/10.1002\/cncr.10203.","journal-title":"Cancer"},{"key":"2328_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00535-021-01783-2","volume":"56","author":"T Kobayashi","year":"2021","unstructured":"Kobayashi T, Omori Y, Ono Y, et al. Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2021;56:581\u201392. https:\/\/doi.org\/10.1007\/s00535-021-01783-2.","journal-title":"J Gastroenterol"},{"key":"2328_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gutjnl-2021-326550","volume":"72","author":"ST Liffers","year":"2023","unstructured":"Liffers ST, Godfrey L, Frohn L, et al. Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype. Gut. 2023;72:522\u201334. https:\/\/doi.org\/10.1136\/gutjnl-2021-326550.","journal-title":"Gut"},{"key":"2328_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00428-020-02827-3","volume":"477","author":"M No\u00eb","year":"2020","unstructured":"No\u00eb M, Brosens LAA. Gastric- and intestinal-type IPMN: two of a kind? Virchows Arch. 2020;477:17\u20139. https:\/\/doi.org\/10.1007\/s00428-020-02827-3.","journal-title":"Virchows Arch"},{"issue":"3","key":"2328_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/path.4344","volume":"233","author":"E Amato","year":"2014","unstructured":"Amato E, Molin MD, Mafficini A, Yu J, Malleo G, Rusev B, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014;233(3):217\u201327. https:\/\/doi.org\/10.1002\/path.4344.","journal-title":"J Pathol"},{"key":"2328_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1053\/j.gastro.2019.06.001","volume":"157","author":"CG Fischer","year":"2019","unstructured":"Fischer CG, Beleva Guthrie V, Braxton AM, et al. Intraductal papillary mucinous neoplasms arise from multiple independent clones, each with distinct mutations. Gastroenterology. 2019;157:1123-37.e22. https:\/\/doi.org\/10.1053\/j.gastro.2019.06.001.","journal-title":"Gastroenterology"},{"key":"2328_CR31","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","volume":"30","author":"A Singhal","year":"2024","unstructured":"Singhal A, Li BT, O\u2019Reilly EM. Targeting KRAS in cancer. Nat Med. 2024;30:969\u201383. https:\/\/doi.org\/10.1038\/s41591-024-02903-0.","journal-title":"Nat Med"},{"key":"2328_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s1535-6108(03)00309-x","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437\u201350. https:\/\/doi.org\/10.1016\/s1535-6108(03)00309-x.","journal-title":"Cancer Cell"},{"key":"2328_CR33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying H, Kimmelman AC, Lyssiotis CA, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012;149:656\u201370. https:\/\/doi.org\/10.1016\/j.cell.2012.01.058.","journal-title":"Cell"},{"key":"2328_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/340692a0","volume":"340","author":"CA Landis","year":"1989","unstructured":"Landis CA, Masters SB, Spada A, et al. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature. 1989;340:692\u20136. https:\/\/doi.org\/10.1038\/340692a0.","journal-title":"Nature"},{"key":"2328_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/srep00161","volume":"1","author":"T Furukawa","year":"2011","unstructured":"Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011;1:161. https:\/\/doi.org\/10.1038\/srep00161.","journal-title":"Sci Rep"},{"key":"2328_CR36","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41556-018-0122-3","volume":"20","author":"KC Patra","year":"2018","unstructured":"Patra KC, Kato Y, Mizukami Y, et al. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Nat Cell Biol. 2018;20:811\u201322. https:\/\/doi.org\/10.1038\/s41556-018-0122-3.","journal-title":"Nat Cell Biol"},{"key":"2328_CR37","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gutjnl-2012-302823","volume":"62","author":"M Kanda","year":"2013","unstructured":"Kanda M, Knight S, Topazian M, et al. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013;62:1024\u201333. https:\/\/doi.org\/10.1136\/gutjnl-2012-302823.","journal-title":"Gut"},{"key":"2328_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1457452","volume":"2020","author":"XY Chang","year":"2020","unstructured":"Chang XY, Wu Y, Jiang Y, et al. Mutations in IPMN cases: a potential prognostic factor. Gastroenterol Res Pract. 2020;2020:1457452. https:\/\/doi.org\/10.1155\/2020\/1457452.","journal-title":"Gastroenterol Res Pract"},{"key":"2328_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040705","author":"J Evans","year":"2025","unstructured":"Evans J, Shivok K, Chen HH, et al. Correlation of GNAS mutational status with oncologic outcomes in patients with resected intraductal papillary mucinous neoplasms. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17040705.","journal-title":"Cancers (Basel)"},{"key":"2328_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00535-021-01846-4","volume":"57","author":"H Kawabata","year":"2022","unstructured":"Kawabata H, Ono Y, Tamamura N, et al. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. J Gastroenterol. 2022;57:208\u201320. https:\/\/doi.org\/10.1007\/s00535-021-01846-4.","journal-title":"J Gastroenterol"},{"issue":"3","key":"2328_CR41","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/PAS.0000000000000117","volume":"38","author":"H Matthaei","year":"2014","unstructured":"Matthaei H, Wu J, Dal Molin M, Shi C, Perner S, Kristiansen G, et al. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as \u201cincipient IPMNs.\u201d Am J Surg Pathol. 2014;38(3):360\u20133. https:\/\/doi.org\/10.1097\/PAS.0000000000000117.","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2328_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3729","volume":"26","author":"X Huo","year":"2024","unstructured":"Huo X, Han W, Yang Z, Lu Y, Liu N, Hou H. RNF43 in cancer: molecular understanding and clinical significance in immunotherapy. J Gene Med. 2024;26(8):e3729. https:\/\/doi.org\/10.1002\/jgm.3729.","journal-title":"J Gene Med"},{"issue":"1","key":"2328_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3787","volume":"4","author":"M Zebisch","year":"2013","unstructured":"Zebisch M, Xu Y, Krastev C, MacDonald BT, Chen M, Gilbert RJC, et al. Structural and molecular basis of ZNRF3\/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat Commun. 2013;4(1):2787. https:\/\/doi.org\/10.1038\/ncomms3787.","journal-title":"Nat Commun"},{"issue":"7413","key":"2328_CR44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nature11308","volume":"488","author":"BK Koo","year":"2012","unstructured":"Koo BK, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M, et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature. 2012;488(7413):665\u20139. https:\/\/doi.org\/10.1038\/nature11308.","journal-title":"Nature"},{"issue":"49","key":"2328_CR45","doi-asserted-by":"publisher","first-page":"31384","DOI":"10.1074\/jbc.271.49.31384","volume":"271","author":"LA Garrett-Sinha","year":"1996","unstructured":"Garrett-Sinha LA, Eberspaecher H, Seldin MF, de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem. 1996;271(49):31384\u201390. https:\/\/doi.org\/10.1074\/jbc.271.49.31384.","journal-title":"J Biol Chem"},{"key":"2328_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41420-023-01416-y","volume":"9","author":"Z He","year":"2023","unstructured":"He Z, He J, Xie K. KLF4 transcription factor in tumorigenesis. Cell Death Discov. 2023;9:118. https:\/\/doi.org\/10.1038\/s41420-023-01416-y.","journal-title":"Cell Death Discov"},{"issue":"5","key":"2328_CR47","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1136\/gutjnl-2020-321217","volume":"70","author":"K Fujikura","year":"2021","unstructured":"Fujikura K, Hosoda W, Felsenstein M, Song Q, Reiter JG, Zheng L, et al. <article-title update=\"added\"> Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions. Gut. 2021;70(5):928\u201339. https:\/\/doi.org\/10.1136\/gutjnl-2020-321217.","journal-title":"Gut"},{"issue":"1","key":"2328_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/0008-5472.CAN-20-1293","volume":"81","author":"K Ganguly","year":"2021","unstructured":"Ganguly K, Krishn SR, Rachagani S, Jahan R, Shah A, Nallasamy P, et al. Secretory mucin 5AC promotes neoplastic progression by augmenting KLF4-mediated pancreatic cancer cell stemness. Cancer Res. 2021;81(1):91\u2013102. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1293.","journal-title":"Cancer Res"},{"issue":"18","key":"2328_CR49","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-17-0387","volume":"23","author":"VK Xie","year":"2017","unstructured":"Xie VK, Li Z, Yan Y, Jia Z, Zuo X, Ju Z, et al. DNA-methyltransferase 1 induces dedifferentiation of pancreatic cancer cells through silencing of Kr\u00fcppel-like factor 4 expression. Clin Cancer Res. 2017;23(18):5585\u201397. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0387.","journal-title":"Clin Cancer Res"},{"key":"2328_CR50","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/CBM-160660","volume":"17","author":"Z Yang","year":"2016","unstructured":"Yang Z, Li D, Liu Z, et al. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance. Cancer Biomark. 2016;17:437\u201344. https:\/\/doi.org\/10.3233\/CBM-160660.","journal-title":"Cancer Biomark"},{"issue":"12","key":"2328_CR51","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1158\/0008-5472.CAN-07-5953","volume":"68","author":"D Wei","year":"2008","unstructured":"Wei D, Kanai M, Jia Z, Le X, Xie K. <article-title update=\"added\"> Kru\u0308ppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res. 2008;68(12):4631\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5953.","journal-title":"Cancer Res"},{"issue":"8","key":"2328_CR52","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1158\/0008-5472.CAN-15-1691","volume":"76","author":"Y Yan","year":"2016","unstructured":"Yan Y, Li Z, Kong X, Jia Z, Zuo X, Gagea M, et al. KLF4-mediated suppression of CD44 signaling negatively impacts pancreatic cancer stemness and metastasis. Cancer Res. 2016;76(8):2419\u201331. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1691.","journal-title":"Cancer Res"},{"issue":"3","key":"2328_CR53","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1078-0432.CCR-16-1064","volume":"23","author":"K Guo","year":"2017","unstructured":"Guo K, Cui J, Quan M, Xie D, Jia Z, Wei D, et al. The novel KLF4\/MSI2 signaling pathway regulates growth and metastasis of pancreatic cancer. Clin Cancer Res. 2017;23(3):687\u201396. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1064.","journal-title":"Clin Cancer Res"},{"key":"2328_CR54","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.pan.2025.09.028","volume":"25","author":"Y Nagamine","year":"2025","unstructured":"Nagamine Y, Tomita M, Yamakuchi M, et al. Effects of Kr\u00fcppel-like factor 4 mutation on the clinicopathological characteristics and its related protein expressions in intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2025;25:1126\u201331. https:\/\/doi.org\/10.1016\/j.pan.2025.09.028.","journal-title":"Pancreatology"},{"issue":"16","key":"2328_CR55","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1158\/0008-5472.CAN-21-4390","volume":"82","author":"Y Makino","year":"2022","unstructured":"Makino Y, Hikita H, Fukumoto K, Sung JH, Sakano Y, Murai K, et al. <article-title update=\"added\">Constitutive activation of the tumor suppressor p53 in hepatocytes paradoxically promotes non\u2013cell autonomous liver carcinogenesis. Cancer Res. 2022;82(16):2860\u201373. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4390.","journal-title":"Cancer Res"},{"key":"2328_CR56","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cgh.2012.11.016","volume":"11","author":"M Kanda","year":"2013","unstructured":"Kanda M, Sadakari Y, Borges M, et al. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol. 2013;11:719-30.e5. https:\/\/doi.org\/10.1016\/j.cgh.2012.11.016.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2328_CR57","unstructured":"Adam MP, Feldman J, Mirzaa GM, et al. GeneReviews. In: 1993."},{"key":"2328_CR58","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2018.10.029","volume":"156","author":"Y Omori","year":"2019","unstructured":"Omori Y, Ono Y, Tanino M, et al. Pathways of progression from intraductal papillary mucinous neoplasm to pancreatic ductal adenocarcinoma based on molecular features. Gastroenterology. 2019;156:647-61.e2. https:\/\/doi.org\/10.1053\/j.gastro.2018.10.029.","journal-title":"Gastroenterology"},{"key":"2328_CR59","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gut.50.6.861","volume":"50","author":"AV Biankin","year":"2002","unstructured":"Biankin AV, Biankin SA, Kench JG, et al. Aberrant p16(INK4A) and DPC4\/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut. 2002;50:861\u20138. https:\/\/doi.org\/10.1136\/gut.50.6.861.","journal-title":"Gut"},{"key":"2328_CR60","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2016-313586","volume":"67","author":"AD Singhi","year":"2018","unstructured":"Singhi AD, McGrath K, Brand RE, et al. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Gut. 2018;67:2131\u201341. https:\/\/doi.org\/10.1136\/gutjnl-2016-313586.","journal-title":"Gut"},{"issue":"4","key":"2328_CR61","doi-asserted-by":"publisher","first-page":"e789","DOI":"10.1097\/sla.0000000000005904","volume":"278","author":"MN Nikiforova","year":"2023","unstructured":"Nikiforova MN, Wald AI, Spagnolo DM, Melan MA, Grupillo M, Lai Y-T, et al. A combined DNA\/RNA-based next-generation sequencing platform to improve the classification of pancreatic cysts and early detection of pancreatic cancer arising from pancreatic cysts. Ann Surg. 2023;278(4):e789\u201397. https:\/\/doi.org\/10.1097\/sla.0000000000005904.","journal-title":"Ann Surg"},{"key":"2328_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2022.09.028","volume":"164","author":"A Paniccia","year":"2023","unstructured":"Paniccia A, Polanco PM, Boone BA, et al. Prospective, multi-institutional, real-time next-generation sequencing of pancreatic cyst fluid reveals diverse genomic alterations that improve the clinical management of pancreatic cysts. Gastroenterology. 2023;164:117-33.e7. https:\/\/doi.org\/10.1053\/j.gastro.2022.09.028.","journal-title":"Gastroenterology"},{"key":"2328_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.gie.2025.01.005","volume":"102","author":"AR Jones","year":"2025","unstructured":"Jones AR, Bardhi O, Polanco P, et al. Clinical utility of incorporating next-generation sequencing results in the management algorithm of pancreatic cysts. Gastrointest Endosc. 2025;102:223-32.e3. https:\/\/doi.org\/10.1016\/j.gie.2025.01.005.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"2328_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01003-7","volume":"9","author":"HE Marei","year":"2025","unstructured":"Marei HE. Epigenetic regulators in cancer therapy and progression. NPJ Precis Oncol. 2025;9(1):206. https:\/\/doi.org\/10.1038\/s41698-025-01003-7.","journal-title":"NPJ Precis Oncol"},{"key":"2328_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"key":"2328_CR66","first-page":"7213","volume":"62","author":"JA Fahrner","year":"2002","unstructured":"Fahrner JA, Eguchi S, Herman JG, et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 2002;62:7213\u20138.","journal-title":"Cancer Res"},{"key":"2328_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/gast.2002.34160","volume":"123","author":"N Sato","year":"2002","unstructured":"Sato N, Ueki T, Fukushima N, et al. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology. 2002;123:365\u201372. https:\/\/doi.org\/10.1053\/gast.2002.34160.","journal-title":"Gastroenterology"},{"issue":"3","key":"2328_CR68","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/1078-0432.CCR-11-1718","volume":"18","author":"SM Hong","year":"2012","unstructured":"Hong SM, Omura N, Vincent A, Li A, Knight S, Yu J, et al. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2012;18(3):700\u201312. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1718.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"2328_CR69","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1158\/1078-0432.CCR-16-2244","volume":"23","author":"T Hata","year":"2017","unstructured":"Hata T, Dal Molin M, Hong SM, Tamura K, Suenaga M, Yu J, et al. Predicting the grade of dysplasia of pancreatic cystic neoplasms using cyst fluid DNA methylation markers. Clin Cancer Res. 2017;23(14):3935\u201344. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2244.","journal-title":"Clin Cancer Res"},{"key":"2328_CR70","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/sj.onc.1208050","volume":"24","author":"N Sato","year":"2005","unstructured":"Sato N, Parker AR, Fukushima N, et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene. 2005;24:850\u20138. https:\/\/doi.org\/10.1038\/sj.onc.1208050.","journal-title":"Oncogene"},{"issue":"11","key":"2328_CR71","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/j.1349-7006.2006.00308.x","volume":"97","author":"P Jiang","year":"2006","unstructured":"Jiang P, Watanabe H, Okada G, Ohtsubo K, Mouri H, Tsuchiyama T, et al. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma. Cancer Sci. 2006;97(11):1267\u201373. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00308.x.","journal-title":"Cancer Sci"},{"key":"2328_CR72","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1245\/s10434-020-08291-2","volume":"27","author":"Y Fujiyama","year":"2020","unstructured":"Fujiyama Y, Kumamoto Y, Nishizawa N, et al. Promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in intraductal papillary mucinous neoplasm (IPMN). Ann Surg Oncol. 2020;27:4007\u201316. https:\/\/doi.org\/10.1245\/s10434-020-08291-2.","journal-title":"Ann Surg Oncol"},{"key":"2328_CR73","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/MPA.0000000000001002","volume":"47","author":"T Nakazato","year":"2018","unstructured":"Nakazato T, Suzuki Y, Tanaka R, et al. Effect of Reprimo Down-regulation on malignant transformation of intraductal papillary mucinous neoplasm. Pancreas. 2018;47:291\u20135. https:\/\/doi.org\/10.1097\/MPA.0000000000001002.","journal-title":"Pancreas"},{"issue":"37","key":"2328_CR74","doi-asserted-by":"publisher","first-page":"30897","DOI":"10.1074\/jbc.R111.309302","volume":"287","author":"G Euskirchen","year":"2012","unstructured":"Euskirchen G, Auerbach RK, Snyder M. SWI\/SNF chromatin-remodeling factors: multiscale analyses and diverse functions. J Biol Chem. 2012;287(37):30897\u2013905. https:\/\/doi.org\/10.1074\/jbc.R111.309302.","journal-title":"J Biol Chem"},{"key":"2328_CR75","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","volume":"17","author":"P Mittal","year":"2020","unstructured":"Mittal P, Roberts CWM. The SWI\/SNF complex in cancer - biology, biomarkers and therapy. Nat Rev Clin Oncol. 2020;17:435\u201348. https:\/\/doi.org\/10.1038\/s41571-020-0357-3.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"2328_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055119","volume":"8","author":"AH Shain","year":"2013","unstructured":"Shain AH, Pollack JR. The spectrum of SWI\/SNF mutations, ubiquitous in human cancers. PLoS ONE. 2013;8(1):e55119. https:\/\/doi.org\/10.1371\/journal.pone.0055119.","journal-title":"PLoS ONE"},{"issue":"6","key":"2328_CR77","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45(6):592\u2013601. https:\/\/doi.org\/10.1038\/ng.2628.","journal-title":"Nat Genet"},{"issue":"2","key":"2328_CR78","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ng.3744","volume":"49","author":"R Mathur","year":"2017","unstructured":"Mathur R, Alver BH, San Roman AK, Wilson BG, Wang X, Agoston AT, et al. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat Genet. 2017;49(2):296\u2013302. https:\/\/doi.org\/10.1038\/ng.3744.","journal-title":"Nat Genet"},{"issue":"2","key":"2328_CR79","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/0008-5472.CAN-19-3922","volume":"81","author":"H Tomihara","year":"2021","unstructured":"Tomihara H, Carbone F, Perelli L, Huang JK, Soeung M, Rose JL, et al. Loss of ARID1A promotes epithelial-mesenchymal transition and sensitizes pancreatic tumors to proteotoxic stress. Cancer Res. 2021;81(2):332\u201343. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3922.","journal-title":"Cancer Res"},{"key":"2328_CR80","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","volume":"7","author":"YF Gu","year":"2017","unstructured":"Gu YF, Cohn S, Christie A, et al. Modeling renal cell carcinoma in mice: Cancer Discov. 2017;7:900\u201317. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0292.","journal-title":"Cancer Discov"},{"issue":"4","key":"2328_CR81","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.humpath.2011.06.009","volume":"43","author":"M Dal Molin","year":"2012","unstructured":"Dal Molin M, Hong SM, Hebbar S, Sharma R, Scrimieri F, de Wil RF, et al. Loss of expression of the SWI\/SNF chromatin remodeling subunit BRG1\/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. Hum Pathol. 2012;43(4):585\u201391. https:\/\/doi.org\/10.1016\/j.humpath.2011.06.009.","journal-title":"Hum Pathol"},{"key":"2328_CR82","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1053\/j.gastro.2021.12.254","volume":"162","author":"H Kato","year":"2022","unstructured":"Kato H, Tateishi K, Fujiwara H, et al. MNX1-HNF1B axis is indispensable for intraductal papillary mucinous neoplasm lineages. Gastroenterology. 2022;162:1272-87.e16. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.254.","journal-title":"Gastroenterology"},{"issue":"5","key":"2328_CR83","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005;7(5):469\u201383. https:\/\/doi.org\/10.1016\/j.ccr.2005.04.023.","journal-title":"Cancer Cell"},{"issue":"24","key":"2328_CR84","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1101\/gad.943001","volume":"15","author":"EL Jackson","year":"2001","unstructured":"Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001;15(24):3243\u20138. https:\/\/doi.org\/10.1101\/gad.943001.","journal-title":"Genes Dev"},{"issue":"18","key":"2328_CR85","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/onc.2015.294","volume":"35","author":"K Taki","year":"2016","unstructured":"Taki K, Ohmuraya M, Tanji E, Komatsu H, Hashimoto D, Semba K, et al. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm. Oncogene. 2016;35(18):2407\u201312. https:\/\/doi.org\/10.1038\/onc.2015.294.","journal-title":"Oncogene"},{"key":"2328_CR86","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2018.08.006","volume":"155","author":"N Ideno","year":"2018","unstructured":"Ideno N, Yamaguchi H, Ghosh B, et al. GNAS. Gastroenterology. 2018;155:1593-607.e12. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.006.","journal-title":"Gastroenterology"},{"key":"2328_CR87","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1053\/j.gastro.2021.12.273","volume":"162","author":"AN Hosein","year":"2022","unstructured":"Hosein AN, Dangol G, Okumura T, et al. Loss of Rnf43 accelerates Kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma. Gastroenterology. 2022;162:1303\u201318. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.273.","journal-title":"Gastroenterology"},{"issue":"1","key":"2328_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ame2.12203","volume":"5","author":"X Zhou","year":"2022","unstructured":"Zhou X, Sun Z, Zhang M, Qu X, Yang S, Wang L, et al. Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation. Anim Models Exp Med. 2022;5(1):61\u201371. https:\/\/doi.org\/10.1002\/ame2.12203.","journal-title":"Anim Models Exp Med"},{"key":"2328_CR89","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/gutjnl-2024-332255","volume":"74","author":"X Zuo","year":"2025","unstructured":"Zuo X, Wang L, Liu Y, et al. Dysregulated KLF4 expression plays a pivotal role in the pathogenesis of pancreatic intraductal papillary mucinous neoplasms. Gut. 2025;74:327\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2024-332255.","journal-title":"Gut"},{"key":"2328_CR90","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1101\/gad.1478706","volume":"20","author":"N Bardeesy","year":"2006","unstructured":"Bardeesy N, Cheng KH, Berger JH, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 2006;20:3130\u201346. https:\/\/doi.org\/10.1101\/gad.1478706.","journal-title":"Genes Dev"},{"key":"2328_CR91","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ncb2916","volume":"16","author":"G von Figura","year":"2014","unstructured":"von Figura G, Fukuda A, Roy N, et al. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol. 2014;16:255\u201367. https:\/\/doi.org\/10.1038\/ncb2916.","journal-title":"Nat Cell Biol"},{"key":"2328_CR92","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.gastro.2018.03.039","volume":"155","author":"Y Kimura","year":"2018","unstructured":"Kimura Y, Fukuda A, Ogawa S, et al. ARID1A maintains differentiation of pancreatic ductal cells and inhibits development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2018;155:194-209.e2. https:\/\/doi.org\/10.1053\/j.gastro.2018.03.039.","journal-title":"Gastroenterology"},{"key":"2328_CR93","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc2676","volume":"9","author":"DB Shackelford","year":"2009","unstructured":"Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009;9:563\u201375. https:\/\/doi.org\/10.1038\/nrc2676.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2328_CR94","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1097\/SLA.0000000000004842","volume":"277","author":"Y Omori","year":"2023","unstructured":"Omori Y, Ono Y, Morikawa T, Motoi F, Higuchi R, Yamamoto M, et al. Serine\/Threonine kinase 11 plays a canonical role in malignant progression of KRAS-mutant and GNAS-wild-type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2023;277(2):e384\u201395. https:\/\/doi.org\/10.1097\/SLA.0000000000004842.","journal-title":"Ann Surg"},{"key":"2328_CR95","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/gutjnl-2018-318059","volume":"69","author":"L Collet","year":"2020","unstructured":"Collet L, Ghurburrun E, Meyers N, et al. <article-title update=\"added\">Kras and Lkb1 mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells. Gut. 2020;69:704\u201314. https:\/\/doi.org\/10.1136\/gutjnl-2018-318059.","journal-title":"Gut"},{"issue":"2","key":"2328_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087875","volume":"9","author":"H Komatsu","year":"2014","unstructured":"Komatsu H, Tanji E, Sakata N, Aoki T, Motoi F, Naitoh T, et al. A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes. PLoS ONE. 2014;9(2):e87875. https:\/\/doi.org\/10.1371\/journal.pone.0087875.","journal-title":"PLoS ONE"},{"issue":"1","key":"2328_CR97","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/gutjnl-2024-332412","volume":"74","author":"Y Makino","year":"2024","unstructured":"Makino Y, Rajapakshe KI, Chellakkan Selvanesan B, Okumura T, Date K, Dutta P, et al. Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas. Gut. 2024;74(1):75\u201388. https:\/\/doi.org\/10.1136\/gutjnl-2024-332412.","journal-title":"Gut"},{"key":"2328_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216607","volume":"584","author":"J Li","year":"2024","unstructured":"Li J, Wei T, Ma K, Zhang J, Lu J, Zhao J, et al. Single-cell RNA sequencing highlights epithelial and microenvironmental heterogeneity in malignant progression of pancreatic ductal adenocarcinoma. Cancer Lett. 2024;584:216607. https:\/\/doi.org\/10.1016\/j.canlet.2024.216607.","journal-title":"Cancer Lett"},{"issue":"7","key":"2328_CR99","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1158\/1078-0432.CCR-18-1955","volume":"25","author":"V Bernard","year":"2019","unstructured":"Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, et al. Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. Clin Cancer Res. 2019;25(7):2194\u2013205. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1955.","journal-title":"Clin Cancer Res"},{"key":"2328_CR100","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1158\/2159-8290.CD-22-1200","volume":"13","author":"M Sans","year":"2023","unstructured":"Sans M, Makino Y, Min J, et al. Spatial transcriptomics of intraductal papillary mucinous neoplasms of the pancreas identifies NKX6-2 as a driver of gastric differentiation and indolent biological potential. Cancer Discov. 2023;13:1844\u201361. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-1200.","journal-title":"Cancer Discov"},{"key":"2328_CR101","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1038\/s41467-024-46994-2","volume":"15","author":"A Agostini","year":"2024","unstructured":"Agostini A, Piro G, Inzani F, et al. Identification of spatially-resolved markers of malignant transformation in intraductal papillary mucinous neoplasms. Nat Commun. 2024;15:2764. https:\/\/doi.org\/10.1038\/s41467-024-46994-2.","journal-title":"Nat Commun"},{"key":"2328_CR102","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade4582","volume":"9","author":"MK Iyer","year":"2023","unstructured":"Iyer MK, Shi C, Eckhoff AM, et al. Digital spatial profiling of intraductal papillary mucinous neoplasms: toward a molecular framework for risk stratification. Sci Adv. 2023;9:eade4582. https:\/\/doi.org\/10.1126\/sciadv.ade4582.","journal-title":"Sci Adv"},{"issue":"9","key":"2328_CR103","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1158\/1078-0432.CCR-24-1529","volume":"31","author":"MK Iyer","year":"2025","unstructured":"Iyer MK, Fletcher AA, Okoye JO, Shi C, Chen F, Kanu EN, et al. Spatial transcriptomics of intraductal papillary mucinous neoplasms reveals divergent indolent and malignant states. Clin Cancer Res. 2025;31(9):1796\u2013808. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-1529.","journal-title":"Clin Cancer Res"},{"key":"2328_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, et al. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Ther"},{"key":"2328_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.08.001","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lih TM, Lee JW, et al. Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression. Cancer Cell. 2025. https:\/\/doi.org\/10.1016\/j.ccell.2025.08.001.","journal-title":"Cancer Cell"},{"key":"2328_CR106","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X. Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther. 2024;9:194. https:\/\/doi.org\/10.1038\/s41392-024-01886-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2328_CR107","doi-asserted-by":"publisher","first-page":"13191","DOI":"10.1038\/s41598-023-39220-4","volume":"13","author":"H Nieminen","year":"2023","unstructured":"Nieminen H, Nummela P, Satomaa T, et al. N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm. Sci Rep. 2023;13:13191. https:\/\/doi.org\/10.1038\/s41598-023-39220-4.","journal-title":"Sci Rep"},{"key":"2328_CR108","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aaw3145","volume":"364","author":"DD Engle","year":"2019","unstructured":"Engle DD, Tiriac H, Rivera KD, et al. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science. 2019;364:1156\u201362. https:\/\/doi.org\/10.1126\/science.aaw3145.","journal-title":"Science"},{"key":"2328_CR109","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1074\/jbc.271.1.413","volume":"271","author":"NP Skiba","year":"1996","unstructured":"Skiba NP, Bae H, Hamm HE. Mapping of effector binding sites of transducin alpha-subunit using G alpha t\/G alpha i1 chimeras. J Biol Chem. 1996;271:413\u201324. https:\/\/doi.org\/10.1074\/jbc.271.1.413.","journal-title":"J Biol Chem"},{"issue":"7","key":"2328_CR110","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1074\/jbc.AW119.003226","volume":"294","author":"GW Hart","year":"2019","unstructured":"Hart GW. Nutrient regulation of signaling and transcription. J Biol Chem. 2019;294(7):2211\u201331. https:\/\/doi.org\/10.1074\/jbc.AW119.003226.","journal-title":"J Biol Chem"},{"key":"2328_CR111","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1158\/2159-8290.CD-19-0297","volume":"10","author":"P Dey","year":"2020","unstructured":"Dey P, Li J, Zhang J, et al. Oncogenic KRAS-driven metabolic reprogramming in pancreatic cancer cells utilizes cytokines from the tumor microenvironment. Cancer Discov. 2020;10:608\u201325. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0297.","journal-title":"Cancer Discov"},{"key":"2328_CR112","doi-asserted-by":"publisher","unstructured":"Trinh VQ, Ankenbauer KE, Torbit SM, et al. Mutant GNAS drives a pyloric metaplasia with tumor suppressive glycans in intraductal papillary mucinous neoplasia. bioRxiv. 2025. https:\/\/doi.org\/10.1101\/2024.02.25.581948","DOI":"10.1101\/2024.02.25.581948"},{"key":"2328_CR113","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s42255-025-01259-0","volume":"7","author":"H Ren","year":"2025","unstructured":"Ren H, Tang Y, Zhang D. The emerging role of protein L-lactylation in metabolic regulation and cell signalling. Nat Metab. 2025;7:647\u201364. https:\/\/doi.org\/10.1038\/s42255-025-01259-0.","journal-title":"Nat Metab"},{"issue":"10","key":"2328_CR114","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/gutjnl-2025-335220","volume":"74","author":"Y Chen","year":"2025","unstructured":"Chen Y, Ballar\u00f2 R, Sans M, Thege FI, Zuo M, Dou R, et al. Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers. Gut. 2025;74(10):1638\u201352. https:\/\/doi.org\/10.1136\/gutjnl-2025-335220.","journal-title":"Gut"},{"key":"2328_CR115","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025.","journal-title":"Immunity"},{"key":"2328_CR116","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1159\/000320696","volume":"10","author":"K Tsutsumi","year":"2010","unstructured":"Tsutsumi K, Ohtsuka T, Oda Y, et al. A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype. Pancreatology. 2010;10:707\u201312. https:\/\/doi.org\/10.1159\/000320696.","journal-title":"Pancreatology"},{"issue":"1","key":"2328_CR117","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000481232","volume":"93","author":"M Takenaka","year":"2017","unstructured":"Takenaka M, Masuda A, Shiomi H, Yagi Y, Zen Y, Sakai A, et al. Chronic pancreatitis finding by endoscopic ultrasonography in the pancreatic parenchyma of intraductal papillary mucinous neoplasms is associated with invasive intraductal papillary mucinous carcinoma. Oncology. 2017;93(1):61\u20138. https:\/\/doi.org\/10.1159\/000481232.","journal-title":"Oncology"},{"key":"2328_CR118","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jamcollsurg.2017.07.521","volume":"225","author":"MT Yip-Schneider","year":"2017","unstructured":"Yip-Schneider MT, Carr RA, Wu H, et al. Prostaglandin E. J Am Coll Surg. 2017;225:481\u20137. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.07.521.","journal-title":"J Am Coll Surg"},{"key":"2328_CR119","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1158\/1078-0432.CCR-10-1561","volume":"17","author":"AV Maker","year":"2011","unstructured":"Maker AV, Katabi N, Qin LX, et al. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2011;17:1502\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1561.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2328_CR120","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s11605-015-2973-2","volume":"19","author":"K Arima","year":"2015","unstructured":"Arima K, Okabe H, Hashimoto D, Chikamoto A, Kuroki H, Taki K, et al. The neutrophil-to-lymphocyte ratio predicts malignant potential in intraductal papillary mucinous neoplasms. J Gastrointest Surg. 2015;19(12):2171\u20137. https:\/\/doi.org\/10.1007\/s11605-015-2973-2.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"2328_CR121","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/SLA.0000000000001988","volume":"266","author":"G Gemenetzis","year":"2017","unstructured":"Gemenetzis G, Bagante F, Griffin JF, Rezaee N, Javed AA, Manos LL, et al. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2017;266(2):339\u201345. https:\/\/doi.org\/10.1097\/SLA.0000000000001988.","journal-title":"Ann Surg"},{"key":"2328_CR122","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/MPA.0000000000001342","volume":"48","author":"CA McIntyre","year":"2019","unstructured":"McIntyre CA, Pulvirenti A, Lawrence SA, et al. Neutrophil-to-lymphocyte ratio as a predictor of invasive carcinoma in patients with intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2019;48:832\u20136. https:\/\/doi.org\/10.1097\/MPA.0000000000001342.","journal-title":"Pancreas"},{"key":"2328_CR123","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/MPA.0000000000001202","volume":"48","author":"T Hata","year":"2019","unstructured":"Hata T, Mizuma M, Motoi F, et al. Diagnostic and prognostic impact of neutrophil-to-lymphocyte ratio for intraductal papillary mucinous neoplasms of the pancreas with high-grade dysplasia and associated invasive carcinoma. Pancreas. 2019;48:99\u2013106. https:\/\/doi.org\/10.1097\/MPA.0000000000001202.","journal-title":"Pancreas"},{"key":"2328_CR124","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1186\/s12885-021-08986-z","volume":"21","author":"X Zhuge","year":"2021","unstructured":"Zhuge X, Zhou H, Chen L, et al. The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms. BMC Cancer. 2021;21:1253. https:\/\/doi.org\/10.1186\/s12885-021-08986-z.","journal-title":"BMC Cancer"},{"key":"2328_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102058","author":"S Serafini","year":"2021","unstructured":"Serafini S, Friziero A, Sperti C, et al. The ratio of C-reactive protein to albumin is an independent predictor of malignant intraductal papillary mucinous neoplasms of the pancreas. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10102058.","journal-title":"J Clin Med"},{"key":"2328_CR126","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"key":"2328_CR127","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.cell.2023.03.012","volume":"186","author":"S Bullman","year":"2023","unstructured":"Bullman S. The intratumoral microbiota: from microniches to single cells. Cell. 2023;186:1532\u20134. https:\/\/doi.org\/10.1016\/j.cell.2023.03.012.","journal-title":"Cell"},{"key":"2328_CR128","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-019-1008-0","volume":"18","author":"MY Wei","year":"2019","unstructured":"Wei MY, Shi S, Liang C, et al. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer. 2019;18:97. https:\/\/doi.org\/10.1186\/s12943-019-1008-0.","journal-title":"Mol Cancer"},{"issue":"2","key":"2328_CR129","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/1055-9965.EPI-18-0542","volume":"28","author":"E Del Castillo","year":"2019","unstructured":"Del Castillo E, Meier R, Chung M, Koestler DC, Chen T, Paster BJ, et al. The microbiomes of pancreatic and duodenum tissue overlap and are highly subject specific but differ between pancreatic cancer and noncancer subjects. Cancer Epidemiol Biomarkers Prev. 2019;28(2):370\u201383. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0542.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2328_CR130","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360. https:\/\/doi.org\/10.1126\/science.aah5043.","journal-title":"Science"},{"key":"2328_CR131","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2025.03.002","volume":"112","author":"N Daniel","year":"2025","unstructured":"Daniel N, Farinella R, Belluomini F, Fajkic A, Rizzato C, Sou\u010dek P, et al. The relationship of the microbiome, associated metabolites and the gut barrier with pancreatic cancer. Semin Cancer Biol. 2025;112:43\u201357. https:\/\/doi.org\/10.1016\/j.semcancer.2025.03.002.","journal-title":"Semin Cancer Biol"},{"key":"2328_CR132","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1136\/gutjnl-2018-317458","volume":"68","author":"RA Gaiser","year":"2019","unstructured":"Gaiser RA, Halimi A, Alkharaan H, et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut. 2019;68:2186\u201394. https:\/\/doi.org\/10.1136\/gutjnl-2018-317458.","journal-title":"Gut"},{"key":"2328_CR133","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.surg.2022.10.003","volume":"173","author":"Y Hozaka","year":"2023","unstructured":"Hozaka Y, Oi H, Satake S, et al. Are intratumoral microbiota involved in the progression of intraductal papillary mucinous neoplasms of the pancreas? Surgery. 2023;173:503\u201310. https:\/\/doi.org\/10.1016\/j.surg.2022.10.003.","journal-title":"Surgery"},{"key":"2328_CR134","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380. https:\/\/doi.org\/10.1126\/science.aay9189.","journal-title":"Science"},{"key":"2328_CR135","doi-asserted-by":"publisher","first-page":"2505118","DOI":"10.1080\/19490976.2025.2505118","volume":"17","author":"Y Baba","year":"2025","unstructured":"Baba Y, Tajima K, Yoshimura K. Intestinal and esophageal microbiota in esophageal cancer development and treatment. Gut Microbes. 2025;17:2505118. https:\/\/doi.org\/10.1080\/19490976.2025.2505118.","journal-title":"Gut Microbes"},{"issue":"10","key":"2328_CR136","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, et al. Intratumoral Fusobacterium nucleatum recruits tumor-associated neutrophils to promote gastric cancer progression and immune evasion. Cancer Res. 2025;85(10):1819\u201341. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-2580.","journal-title":"Cancer Res"},{"issue":"7","key":"2328_CR137","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/gutjnl-2023-331012","volume":"73","author":"MM Pust","year":"2024","unstructured":"Pust MM, Rocha Castellanos DM, Rzasa K, Dame A, Pishchany G, Assawasirisin C, et al. Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm. Gut. 2024;73(7):1131\u201341. https:\/\/doi.org\/10.1136\/gutjnl-2023-331012.","journal-title":"Gut"},{"issue":"6","key":"2328_CR138","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/SLA.0000000000006299","volume":"282","author":"AM Eckhoff","year":"2024","unstructured":"Eckhoff AM, Fletcher AA, Kelly MS, Dohlman AB, McIntyre CA, Shen X, et al. Comprehensive assessment of the intrinsic pancreatic microbiome. Ann Surg. 2024;282(6):1060\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000006299.","journal-title":"Ann Surg"},{"issue":"6","key":"2328_CR139","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.pan.2025.08.001","volume":"25","author":"K Fukuda","year":"2025","unstructured":"Fukuda K, Hozaka Y, Oi H, Tomita M, Idichi T, Yamasaki Y, et al. Association between intra-tumoral microbiome and genetic alterations in intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2025;25(6):905\u201311. https:\/\/doi.org\/10.1016\/j.pan.2025.08.001.","journal-title":"Pancreatology"},{"issue":"3","key":"2328_CR140","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/jgh.16437","volume":"39","author":"L Zou","year":"2024","unstructured":"Zou L, Mo S, Jia C, Pang J, Chang X, Chen J. The tumoral microbiome of pancreatic intraductal papillary mucinous neoplasm: a single-center retrospective cohort study. J Gastroenterol Hepatol. 2024;39(3):496\u2013505. https:\/\/doi.org\/10.1111\/jgh.16437.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2328_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02576-9","volume":"23","author":"Z Sun","year":"2022","unstructured":"Sun Z, Huang S, Zhu P, Tzehau L, Zhao H, Lv J, et al. Species-resolved sequencing of low-biomass or degraded microbiomes using 2bRAD-M. Genome Biol. 2022;23(1):36. https:\/\/doi.org\/10.1186\/s13059-021-02576-9.","journal-title":"Genome Biol"},{"key":"2328_CR142","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S2468-1253(22)00235-7","volume":"7","author":"T Pollini","year":"2022","unstructured":"Pollini T, Adsay V, Capurso G, et al. The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms. Lancet Gastroenterol Hepatol. 2022;7:1141\u201350. https:\/\/doi.org\/10.1016\/S2468-1253(22)00235-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2328_CR143","doi-asserted-by":"publisher","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","volume":"67","author":"CE Clark","year":"2007","unstructured":"Clark CE, Hingorani SR, Mick R, et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 2007;67:9518\u201327. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0175.","journal-title":"Cancer Res"},{"key":"2328_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102714","volume":"54","author":"S Roth","year":"2020","unstructured":"Roth S, Zamzow K, Gaida MM, Heikenw\u00e4lder M, Tjaden C, Hinz U, et al. Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer. EBioMedicine. 2020;54:102714. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102714.","journal-title":"EBioMedicine"},{"key":"2328_CR145","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1158\/1078-0432.CCR-21-2585","volume":"28","author":"S Hernandez","year":"2022","unstructured":"Hernandez S, Parra ER, Uraoka N, et al. Diminished immune surveillance during histologic progression of intraductal papillary mucinous neoplasms offers a therapeutic opportunity for cancer interception. Clin Cancer Res. 2022;28:1938\u201347. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2585.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2328_CR146","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/path.6402","volume":"266","author":"KT Jamouss","year":"2025","unstructured":"Jamouss KT, Damanakis AI, Cornwell AC, Jongepier M, Trujillo MA, Pfl\u00fcger MJ, et al. Tumor immune microenvironment alterations associated with progression in human intraductal papillary mucinous neoplasms. J Pathol. 2025;266(1):40\u201350. https:\/\/doi.org\/10.1002\/path.6402.","journal-title":"J Pathol"},{"key":"2328_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052953","author":"T Enzler","year":"2024","unstructured":"Enzler T, Shi J, McGue J, et al. A comparison of spatial and phenotypic immune profiles of pancreatic ductal adenocarcinoma and its precursor lesions. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25052953.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2328_CR148","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396. https:\/\/doi.org\/10.1084\/jem.20162024.","journal-title":"J Exp Med"},{"issue":"22","key":"2328_CR149","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1158\/1078-0432.CCR-11-0607","volume":"17","author":"DZ Chang","year":"2011","unstructured":"Chang DZ, Ma Y, Ji B, Wang H, Deng D, Liu Y, et al. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011;17(22):7015\u201323. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0607.","journal-title":"Clin Cancer Res"},{"key":"2328_CR150","doi-asserted-by":"publisher","first-page":"7781","DOI":"10.1245\/s10434-022-12157-0","volume":"29","author":"AM Eckhoff","year":"2022","unstructured":"Eckhoff AM, Fletcher AA, Landa K, et al. Multidimensional immunophenotyping of intraductal papillary mucinous neoplasms reveals novel T cell and macrophage signature. Ann Surg Oncol. 2022;29:7781\u20138. https:\/\/doi.org\/10.1245\/s10434-022-12157-0.","journal-title":"Ann Surg Oncol"},{"key":"2328_CR151","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/MPA.0000000000001047","volume":"47","author":"M Tanaka","year":"2018","unstructured":"Tanaka M. Intraductal papillary mucinous neoplasm of the pancreas as the main focus for early detection of pancreatic adenocarcinoma. Pancreas. 2018;47:544\u201350. https:\/\/doi.org\/10.1097\/MPA.0000000000001047.","journal-title":"Pancreas"},{"key":"2328_CR152","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF02788389","volume":"22","author":"K Yamaguchi","year":"1997","unstructured":"Yamaguchi K, Nakamura K, Yokohata K, et al. Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Report of two cases. Int J Pancreatol. 1997;22:227\u201331. https:\/\/doi.org\/10.1007\/BF02788389.","journal-title":"Int J Pancreatol"},{"issue":"5","key":"2328_CR153","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/s0016-5107(97)70039-7","volume":"46","author":"M Tanaka","year":"1997","unstructured":"Tanaka M, Yokohata K, Konomi H, Yamaguchi K, Chijiiwa K, Ohta M. Segmental balloon cytology for preoperative localization of in situ pancreatic cancer. Gastrointest Endosc. 1997;46(5):447\u20139. https:\/\/doi.org\/10.1016\/s0016-5107(97)70039-7.","journal-title":"Gastrointest Endosc"},{"key":"2328_CR154","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pan.2023.11.005","volume":"24","author":"T Yoshioka","year":"2024","unstructured":"Yoshioka T, Shigekawa M, Ikezawa K, et al. The relationship between observation interval and prognosis in pancreatic cancer concomitant with intraductal papillary mucinous neoplasia. Pancreatology. 2024;24:73\u20137. https:\/\/doi.org\/10.1016\/j.pan.2023.11.005.","journal-title":"Pancreatology"},{"issue":"2","key":"2328_CR155","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/SLA.0b013e3182378a18","volume":"255","author":"H Matthaei","year":"2012","unstructured":"Matthaei H, Norris AL, Tsiatis AC, Olino K, Hong SM, dal Molin M, et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012;255(2):326\u201333. https:\/\/doi.org\/10.1097\/SLA.0b013e3182378a18.","journal-title":"Ann Surg"},{"key":"2328_CR156","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2017.07.019","volume":"153","author":"I Pergolini","year":"2017","unstructured":"Pergolini I, Sahora K, Ferrone CR, et al. Long-term risk of pancreatic malignancy in patients with branch duct intraductal papillary mucinous neoplasm in a referral center. Gastroenterology. 2017;153:1284-94.e1. https:\/\/doi.org\/10.1053\/j.gastro.2017.07.019.","journal-title":"Gastroenterology"},{"issue":"1","key":"2328_CR157","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/SLA.0000000000006535","volume":"281","author":"C Assawasirisin","year":"2025","unstructured":"Assawasirisin C, Fagenholz P, Qadan M, Hernandez-Barco Y, Aimprasittichai S, Kambadakone A, et al. Unraveling the long-term natural history of branch duct intraductal papillary mucinous neoplasm: beyond 10 years. Ann Surg. 2025;281(1):154\u201360. https:\/\/doi.org\/10.1097\/SLA.0000000000006535.","journal-title":"Ann Surg"},{"key":"2328_CR158","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.pan.2024.08.013","volume":"24","author":"T Ohtsuka","year":"2024","unstructured":"Ohtsuka T, Maguchi H, Tokunaga S, et al. Prospective multicenter surveillance study of branch-duct intraductal papillary mucinous neoplasm of the pancreas; risk of dual carcinogenesis. Pancreatology. 2024;24:1141\u201351. https:\/\/doi.org\/10.1016\/j.pan.2024.08.013.","journal-title":"Pancreatology"},{"key":"2328_CR159","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/j.gastro.2019.08.032","volume":"158","author":"H Oyama","year":"2020","unstructured":"Oyama H, Tada M, Takagi K, et al. Long-term risk of malignancy in branch-duct intraductal papillary mucinous neoplasms. Gastroenterology. 2020;158:226-37.e5. https:\/\/doi.org\/10.1053\/j.gastro.2019.08.032.","journal-title":"Gastroenterology"},{"key":"2328_CR160","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/MPA.0000000000000258","volume":"44","author":"N Ideno","year":"2015","unstructured":"Ideno N, Ohtsuka T, Matsunaga T, et al. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Pancreas. 2015;44:311\u201320. https:\/\/doi.org\/10.1097\/MPA.0000000000000258.","journal-title":"Pancreas"},{"key":"2328_CR161","doi-asserted-by":"publisher","first-page":"e790","DOI":"10.1097\/MPA.0000000000002373","volume":"53","author":"H Oi","year":"2024","unstructured":"Oi H, Hozaka Y, Akahane T, et al. Genetic assessment of intraductal papillary mucinous neoplasm for predicting concomitant pancreatic ductal adenocarcinoma. Pancreas. 2024;53:e790\u20135. https:\/\/doi.org\/10.1097\/MPA.0000000000002373.","journal-title":"Pancreas"},{"key":"2328_CR162","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1053\/j.gastro.2025.04.032","volume":"169","author":"H Oyama","year":"2025","unstructured":"Oyama H, Hamada T, Nevo D, et al. Relationship of intrapancreatic fat deposition with pancreatic cancer differs according to carcinoma types. Gastroenterology. 2025;169:718-21.e5. https:\/\/doi.org\/10.1053\/j.gastro.2025.04.032.","journal-title":"Gastroenterology"},{"key":"2328_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103996","volume":"79","author":"E Truong","year":"2022","unstructured":"Truong E, Pandol S, Jeon C. Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer. EBioMedicine. 2022;79:103996. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103996.","journal-title":"EBioMedicine"},{"key":"2328_CR164","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00535-023-02024-4","volume":"58","author":"K Takahashi","year":"2023","unstructured":"Takahashi K, Takeda Y, Ono Y, et al. Current status of molecular diagnostic approaches using liquid biopsy. J Gastroenterol. 2023;58:834\u201347. https:\/\/doi.org\/10.1007\/s00535-023-02024-4.","journal-title":"J Gastroenterol"},{"key":"2328_CR165","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000006645","author":"S Yachida","year":"2025","unstructured":"Yachida S, Yoshinaga S, Shiba S, et al. KRAS mutations in duodenal lavage fluid after secretin stimulation for detection of pancreatic cancer. Ann Surg. 2025. https:\/\/doi.org\/10.1097\/sla.0000000000006645.","journal-title":"Ann Surg"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-025-02328-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-025-02328-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:44:29Z","timestamp":1781948669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-025-02328-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":165,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1007\/s00535-025-02328-7","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}